T o investigate tbe mechanism for hyperventiIation in two common but dissimilnt conditions, astbma (A) and lobar pneumonia (P), we examined the ventUatory pattern in 17 A and & P subjects Wben acutely m, byperventilation (PaCO,) was similer in the two groups. Minute ventilation #E) however, was slightly greater in group A than in P. In A patients, measurements of occlusion pressure (dP/dT) and inspiratory flow rate (VT/ t , ) during quiet breathing showed enbancement of respiratory center output. By contrast, in P patients, dP/dT and V T /~, were not elevated, Tidal volume (VT) was 0.59 + 0.19 L in A; 0.45 2 0.09 in P. Respiratory rate was increased in both groups. With supplementary oxygen therypementilation occurs in many acute pulmon q diseases. Current concepts indicate that minute ventilation ( VE ) represents the product of two components, respiratory timing and medullary respiratory center output.' Either of two mechanisms, change in the timing component or increase of \re11 tilatory drive, may cause hypocapnea. Respiratory frequency ( f ) and inspiratory time (ti ), both easily measured in acutely ill patients, are indices of respiratory timing. The occlusion pressure (that subatmospheric mouth pressure developed by isometric contraction of respiratory muscles 100 milliseconds after the onset of an inspiratory effort against an occluded airway) is a noninvasive index of respiratory center output well suited for quantification of ventilatory drive in the acutely ill Tidal volume (VT) and mean inspiratory flow rate ( VT/ t, ) are other easily measured indices of ventilatory drive. In this study, we investigated first the role of each of these two mechanisms in the genesis of hyperventilation during acute illness, and second, the possibility that supplementary oxygen will attenuate either respiratory center output or the timing mechanism.
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apy, neither 9~ nor PaCOr changed in eitber group. The mechanism for the increased ventilatory drive in group A is unclear. Most likely, reflexes initiated by either bronchospasm or by the sudden increase of endsxpiratory lung vdume (EELV), not operative in P, account for the increased respiratory center output seen in A. To examine the latter possibility, we studied the ventilatory pattern at both normal and increased EELV in six nonasthmatic subjects. Both dP/ dT and VT/ t , were increased in all subjects after elevation of EELV. Tbns, cbanges in EELV may be important for the regulation of ventilation during bronchospasm.
\Ve studied patients with reversible airway (asthma ) and alveolar ( pneumonia ) diseases. Patients were assessed by conventional clinical criteria and results of pulmonary function tests. We recorded occlusion pressure, % ' E and its components (VT V~l t , , t,, and f ) in these subjects before therapy, with supplementary oxygen as the only therapy, and, last, after specific bronchodllator or antibiotic therapy. Since this study required that the subject breathe through a mouthpicce, we examined the effect of mouthpiece breathing on both ventilatory drive and the time mechanism. Finally, to examine the possibility that the increased respiratory center output in the asthmatic patient might be caused by changes in functional residual capacity during bronchospasm, we studied ventilatory drive and timing in nonasthmatic subjects at increased end-expiratory lung volume.
Pneumonia patients, selected from the CoIlege Hospital in-patient population, met the following criteria: ( 1) fever, chills, and productive cough of recent onset; ( 2 ) neutm phils and microorganisms demonstrable on sputum Gram stain; and ( 3 ) roentgenographic infiltrates on examination. Patients with clinical evidence for either heart disease or chronic lung disease (eg, chronic respiratory symptoms, evidence for ainvay obstruction, or roentgenographic abnormality other than the infiltrate) were excluded.
Control subjects volunteered from the medical and paramedical stafFs.
All 17 asthmatic subjects performed pulmonary function and ventilatory control studies prior to therapy, and 16 repeated ventilatory control studies after inspiring oxygen, 4 L/min, for ten minutes. To demonstrate that the decrease in occlusion pressure often observed during 0, inhalation did not represent psychologic adaptation to the laboratory setting, we again repeated ventilatory control testing in five patients ten minutes after discontinuation of O.,.
In 12 subjects, both pulmonary function and ventilatory control testing were repeated after bronchodilator therapy. Eight had been treated as outpatients; four were reexamined after a brief hospitalization.
The pneumonia patients were studied within 18 hours of hospital admission. All had received an initial dose of antibiotic therapy by this itme. Some had received nonnarcotic analgesic. Testing was repeated prior to discharge. Criteria for discharge were appreciable resolution of the infiltrate and white blood cell count and body temperature within normal limits.
Procedur es
Pulmonary function tests were performed with a 9-L Collins spirometer. Functional residual capacity and ainvay resistance were measured in a pressure-variable body plethysmograph by the DuBois method.7.s Lung volumes were expressed as a percentage of a predicted value. 9 For studies of ventilatory control, the subjects, seated and wearing nose clips, breathed from a mouthpiece into a low-resistance, one-way valve. To record airway pressure, a needle was inserted into the mouthpiece. The inspiratory limb of the apparatus, which contained both a pneumotachygraph and an occluding valve, was screened from the patient's view. The dead space of this apparatus was approximately 100 ml. Inspiratory flow, tidal volume, and airway pressure were displayed on an oscilloscope ( Electronics for Medicine, DR-8 recorder). The volume signal was calibrated with the spirometer and corrected for BTPS. The inspiratory limb was opened to the atmosphere. For administration of oxygen, a cannula from the oxygen source was placed in the inspiratory limb.
Several methods may be used to quantify occlusion pressure. These include the absolute measurement of subatmospheric airway pressure 0.1 second after the onset of the inspiratory effort (Po., ); the first derivative of airway pressure and time recorded by electronic differentiation (dP/dT); and, dP/dT measured as the slope of the mouth pressure vs time tracing.
To record occlusion pressure ( dP/dT), we occluded the inspiratory line with a manual valve during exhalation. To ensure reproducible and valid occlusion pressure measurements, we observed guidelines established in other laboratories. IVe al!owed at least ten unhindered breaths between occluded breaths. At the onset of the occluded inspiratory effort, the occlusion \+alve was opened promptly; occlusions never persisted for more than 400 milliseconds after the onset of inspiration against the closed valve. We reported dP/dT as the slope of the mouth pressure vs time tracing measured between 0.05 and 0.1 second and expressed as cm H,O in one second.10." To validate the use of dP/dT in the presence of increased functional residual capacity, we measured both dP/dT and V-r/t, in nonasthmatic subjects at both normal and increased end-expiratory lung volume.
The dP/dT measurements represented the average of three or more determinations. Other measurements calculated from the oscilloscope tracing were: tidal volume ( V T ) ; inspiratory time ( t i ) ; mean inspiratory flow ( V r / t i ) ; minute ventilation (vE); and the ratio of inspiration to total duration of the respiratory cycle ( t ,/t,,, ) .
Preliminary observations revealed that administration of oxygen or bronchodilator therapy lessened the occlusion pressure but had little effect on minute ventilation. Other authors previously indicated that in normal subjects, tidal volume during mouthpiece breathing, and therefore minute ventilation, exceeds that measured during natural respiration without a mouthpiece.1We reasoned that this mouthpiece effect on tidal volume might be diminished during bronchospasm. The reappearance of this mouthpiece artifact after bronchodilation may conceal changes in the ventilatory pattern after treatment from the observer. Therefore, we Xormal subject 31f 7 1 1 (9/2) 91f 9 80f 8 *Abbreviations: VC, % =vital capacity, % predicted; FEVI/VC, % =forced expiratory volume in one second tw O/L of VC; FHC, % -functional residual capacity, % predicted; Raw =airway resistance as cm Hz0 L-1 sec-l; ( f ) = SD; n (M /F) = numlwr of subjects (male/female).
MOUTH OFF OF
examined the effect o f a mouthpiece on the ventilatory patStatistical Analysis tern of our subjects before and after bronchodilation.
To evaluate the mouthpiece effect, we compared ribcage and abdominal excursions from pmumogram belt tracings during natural respiration and mouthpiece breathing. We reasoned that changes in the amplitude of chest wall excursion during a respiratory cycle must reflect changes in tidal volume as long as no paradoxic or expiratory abdominal motion could be observed during inspiratiomls Accordingly, during the study, pneurnogrcuns were p!aced at the xyphoid process a d umbilicus in four subjects. None of these subjects demonstrated paradoxic chest wall and abdominal movements during resting ventilation. As shown in Figure 1 , we quantified the mouthpiece effect as the ratio of chest wall excursion during tidal breathing with and without the mouthpiece.
End-Expiratory Lung Volume EIewtior, (EELV) in

N o d m a t i c Subjects
We hypothesized that changes in respiratory center output and timing seen in asthma may result from increased
EELV.
To test this hypothesis, we measured dP/dT, VT, ti, and VT/~, in six normal subjects both at normal and at elevated EELV. To increase EELV, tubing fmm the expiratory port of the breathing valve was immersed under water, from 6 to 8 cm depth. Subjects were instrud to relax during expiration so that EELV might be d e t e d by the recoil of the relaxed respiratory system alone. Measurements of tidal breathing were made from three or more breaths beginning 30 seconds or ten breaths after immersion of the expiratory tubing. At this time, VT appeared to be stable. Changes in EELV were measured with respiratory magnetometers (obtained from Nonnau H. Peterson, Boston). Because the subjects were making a conscious effort to relax during expiration, we did not compute VE or frequency, both of which depend, in part, on expiratory time. 
KASSABIAN, MILLER, UVIETES
To test for differences in age and pulmonary function in the control, asthma, and pneumonia groups, we used the one-way analysis of variance. l 4 To examine the individual d e c t of oxygen and specific therapy on dP/dT, we used the Fnedman rank-sums test.15 Differences between two groups were examined with Student's paired and unpaired t tests. Correlations between airway resistance and measurements of ventilatory control were examined by regression analysis.
Pulmonary function data appear in Table 1 . Normal control subjects were younger than patients ( F = 4.45; P < 0.025). By standard criteria'= vital capacity ( VC ) was moderately decreased in asthmatic subjects (58 t 19 percent) on entry into the study, while functional residual capacity ( FRC ) was increased ( 163 +. 39 percent ) .
Airway obstruction was documented by a decreased FEVl (48 +. 12 percent of VC ) and an increased airway resistance (7.6 2 3.4). After bronchodilation, airway resistance decreased (2.9 t 1.5).
FEVI 1 VC ( percent ) increased after therapy (paired t = 2.73; P <0.05). Nevertheless, persistent airflow obstruction was documented by the FEVl (55 A 14 percent of VC). Similarly, FRC decreased with therapy (paired t = 2.80; P < 0.02) but remained abnormal (137 t 20 percent).
Prior to therapy, VC was minimally decreased in the pneumonia group (06 * 13 percent). After antibiotic and respiratory physical therapy, VC in the pneumonia patients (77 * 14 percent) demonstrated functional improvement (paired t = 3.33; P < 0.025). Of note, pulmonary function improved after therapy in both patient groups. Nevertheless, Eunctional abnormality persisted at the end of the treatment period in both asthma and pneumonia pa tien ts. Arterial blood gas analyses appear in Table 2 . All pH determinations were compatible with acute respiratory alkalosis. All patients had hypoxemia and hypocarbia. As anticipated, P a increased with oxygen administration in both groups. In those five asthmatic subjects who repeated their control 
Occlusion Pressure Measurements
The dP/dT values for asthmatic subjects appear in Figure 2 and Table 3 . In this group, dP/dT measured before therapy, during oxygen supplementation, and repeated without therapy after discontinuation of oxygen was greater than the mean for normal subjects. Measurements of dP/dT at the time of presentation to the emergency service, after oxygen, and again after bronchodilation were available for 12 asthmatic subjects. The rank sums test indicated that both oxygen and bronchodilator treatments attenuated dP/dT (g = 10.17; P = 0.005). By this analysis, the tendency of bronchodilator to reduce dP/dT from control was no greater than that for supplementary oxygen alone. This finding was conftmed by paired t test analysis between dP/dT measurements with oxygen and bronchodilator therapies, respectively. The dP/dT was less after bmnchodilation than with oxygen administration in seven subjects; however, it was no different or slightly greater after bronchohv~.
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dilation, compared with oxygen, in five. In 16 subsubjects. During quiet breathing dp/dt was greatjects dP/dT measurements were available both more, dP/dT returned to or was above the preoxyventilatory studies after withdrawal of supplementary oxygen, Poz at the time of the second control study (62 * 16) was no different from the initial Poz for the entire group ( 85 a 15 ) . Although Pcoz in asthmatic subjects was lower after therapy (26 + 5) than the initial study (31 + 3), this change was not statistically significant. With therapy, Poz increased slightly (71 + 17) in asthmatic subjects. In the pneumonia patients, P a decreased from 33 5 to 28 a 4 with oxygen value in three of five sukects who repeated these measurements after discontinuation of oxygen.
Finally, before-therapv dP/dT varied from 0.99 to 4 .66 cm Hz0 in the 17 asthmatic subjects. The dP/dT measured prior to therapy did not correlate with either Paor or airway resistance measured at the same time. These data demonstrate great individual variability in the intensity of respiratory drive provoked by bronchospasm. The dP/dT data for pneumonia patients appear in Figure 3 and Table 3 ; dPldT in this group was no different from that of the control group.
Characteristics of the Ventilatory Pattern
Data appear in Table 3 ; important findings are illustrated in Figure 4 . In the asthmatic subjects prior to therapy, mean values for VE, V~/ t i , and f were all greater than those for normal subjects, whereas ti and tilttot were diminished. Only f and ti remained beyond the range for normal subjects after therapy. Before any therapeutic intervention, patients with high dP/dT tended to have higher VE than others, although this correlation was not significant ( r = + 0.44; P < 0.10). Addition of either airway resistance or specific airway resistance ( resistance corrected for thoracic gas volume) to the analysis did not enhance this correlation.
The breathing pattern in the pneumonia subjects prior to therapy was unlike that of the asthmatic group. The VE for pneumonia patients (9.2 2 2.4 
Mouthpiece Efect
Measurements of mouthpiece effect ( ME) in three asthmatic subjects appear in Table 4 . Airway resistance and dP/dT measurements before and after bronchodilator therapy in these three subjects are similar to those of the 17 subjects shown in Table 1 and 3. These data indicate that ME may cause an exaggeration of chest cage expansion during resting breathing when ventilation is measured after bronchodilation. ME was negligible dP/dT and VT/ ti increased with elevation of FRC.
-.
- prior to therapy ( 1.1 k 0.1) but substantial when measured after therapy ( 1.9 + 0.2). This difference was significant at the P < 0.025 level. In contrast, the mouthpiece did not alter breathing frequency either before or after therapy. Furthermore, we studied a fourth patient whose Raw was minimally elevated (3.1) prior to therapy and did not change with administration of isoproterenol and theophylline. ME also did not change (1.4
prior to therapy and 1.6 after). This observation supported further our conclusion that the lack of ME during bronchoconstriction and its presence after therapy is related to normalization of airway function.
Ed-Expiratory Lung Volume Elemtion (EELV)
Data in Table 5 represent the average of two trials in all but one subject. In subject 5, a trial was discarded during which dP/dT increased during expiratory loading; paradoxic inward inspiratory abdominal motion occurred, however, and both VT and V T /~~ decreased. End-expiratory airway pressure measured during the one-minute
We found in the asthma subjects evidence for both increased inspiratory drive ( dP/dT and VT/ti ) and altered respiratory timing ( f, ti ). With bronchodilation, inspiratory drive decreased, while the alteration of respiratory timing persisted; hypocapnia persisted as well. Possibly, the artifactual effect of breathing through a mouthpiece may have influenced V T /~~ (and thus VT) while persistent obstruction of small airways may have affected the timing mechanism to account for hyperventilation after the treatment period. In contrast, only the respiratory timing was altered in the pneumonia group.
While many studies have examined simultaneous occlusion pressure and ventilation responses to chemical stimuli in patients with lung disease, few have measured the occlusion pressure during spontaneous breathing in these subjects.= The occlusion pressure measurement during COz stimulation, while a specific test of respiratory center chemosensitivity, requires increasing rates of inspiratory muscle contraction during the rebreathing period.
The achievement of such rates of contraction may be difficult for the asthmatic patients whose inspiratory muscles function at a poor mechanical advantage because of increased thoracic gas volume at endexpiration. The observation that the occlusion pressure in asthmatic patients is greater than in normal controls early during carbon dioxide rebreathing while the rise of occlusion pressure Table 5 Tables 1 and 3 . tDifferent from control group, P <0.02.
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RESPlMTORY CECllER OUTPUT AND VENTIUTORY TIMIN6 541 with increasing PaC02 is less supports the hypothesis that the blunted response to hypercapnia may reflect respiratory muscle dysfunction in asthma.' Therefore, dP/dT as measured in this study, while not a specific index of ventilatory response to chemical stimuli, may be an appropriate index of inspiratory drive in asthma.
Mann et a16 have measured spontaneous ventilation, occlusion pressure, and airway resistance in normal subjects both before and after methylcholine inhalation. A relationship was found between the increase in airway resistance and increase of occlusion pressure, but no systematic change in tidal volume or inspiratory flow ensued This result was not unexpected, because chest wall reflexes, lung reflexes, or conscious mechanisms as well as respiratory center output may affect the tidal breath. In this study, dP/dT was greatly increased in patients with asthma but not pneumonia. Possibly, a difFerence in the degree of hypoxia or level of anxiety could account for this difference in dp/dt between groups. More likely a mechanical factor present only in asthma may account for this difference in ventilatory drive between groups. Conceivably the increased respiratory center output in asthma represents a reflex, or neuromechanical, response to an added resistive load. Both external inspiratory resistive loading and bronchoconstriction (with methacholine) bring about an irnmediate increase in occlusion pressure and inspiratory flow in asthmatic subjects.17 H p p n i a ensues. In that study, changes in ventilatory drive were greater after bronchoconstriction than after external loading.
An alternative possibility is that the increased inspiratory drive in asthma results from a neuromechanical reflex originating in muscle or joint receptors stimulated by the increased end-expiratory lung volume. There is some evidence for this hypothesis in the literature. Kelsen et all8 speculate that the increased occlusion pressure seen in normal persons confronted by an external resistive load originates from chest wall mechanical receptors. Matthews and Howell3 and Green et all9 have provided further support for this possibility. They demonstrated ( with occlusion pressure and diaphragmatic EMG techniques) that normal persons whose functional residual capacity is raised by either positive airway pressure or negative pressure outside of the thorax defend tidal volume by increasing ventilatory drive.
Data from Table 5 demonstrate that increasing end-expiratory lung volume induces changes in the ventilatory drive of normal subjects similar to those seen in asthma. In two subjects (1 and 3) the increase in EELV appeared out of proportion to the expiratory airway pressure. Most likely, these subjects failed to relax inspiratory muscles during expiration. The dP/dT was greatly increased in these subjects. Tonic inspiratory muscle activity during expiration occurs in asthma." These observations raise the possibility that, while dP/dT is an index of medullary respirator)? center output, the increased occlusion pressure during bronchospasm may represent presynaptic facilitation of tonically contracting inspiratory muscles as Because the occlusion pressure is increased in patients with chronic interstitial lung disease, we anticipated an increased dP/dT in the pneumonia
In contrast to the patients in that group with chronic interstitial lung disease, the pneurnonia patients in this study demonstrated normal FRC. Out patients maintained a normal V T /~~ with only minimal augmentation of dP/dT. Their breathing load was therefore not substantially increased over the tidal breath. These observations taken together might indicate that patients with interstitial or alveolar filling disease increase inspiratory center output only to maintain VT/ t i. The dP/ dT may increase above normal only when lung distensibility is decreased over the tidal volume range.
Finally, increased ventilatory drive ( as defined by hypocarbia) persisted in our treated asthmatic patients in spite of a normal dP/dT. To some degree, posttherapy measurements may be infiuenced by mouthpiece artifact. We have demonstrated that mouthpiece breathing enhances tidal volume (probably by increasing inspiratory flow rate) in stable subjects but not in those with severe airway obstruction.
Oxygen Administration
The elevated dP/dT was attenuated by oxygen in our asthmatic subjects but returned to pretreatment values when oxygen was discontinued. Only slight changes in minute ventilation and PaC02 accompanied this reduction of respiratory center output, however. Others have suggested that hypoxic drive may not be important to maintain ventilation in asthma.23 Both the lack of correlation of dP/dT in the untreated asthmatic patients with simultaneously measured Pa02 and failure of oxygen to abolish hyperventilation indicate that hypoxemia was not a major determinant of respiratory center output in our asthmatic patients.
Possibly, oxygen may have affected dP/dT in our subjects indirectly, by bronchodilation, rather than directly by reduction of stimulation to peripheral chemoreceptors. This appears unlikely, however, because bronchoconstriction caused by alveolar hypoxia occurs only when hypoxemia is more severe than in our subjects and hemoglobin desaturation is apparent.*' Finally, it should be noted that the hypoxemia was not severe in either the pneumonia or asthma patient group. That oxygen administration does not alter the ventilatory pattern in the pneumonia patient is well k n~w n .~
Ventilate y Timing
Current concepts indicate that in both asthma and pneumonia, the respiratory rate is modified by vagal inflation-inhibition reflexes.2s28 This reflex, which brings about a slightly decreased inspiratory time, increased frequency, and, often, increased minute ventilation, accounts for hyperventilation in pneumonia patients. Although trends toward normalization of ventilatory timing (increased ti and VT; decreased f ) occurred with treatment in both patient groups, the differences in these indices before and after therapy were not statistically significant. We identify three explanations for the inconsistency of these data: ( 1) the increased ventilatory drive with bronchospasm that protected the tidal volume despite of the increased frequency; ( 2 ) mouthpiece artifact; and ( 3 ) persistent functional abnormality, as defmed by moderate airway obstruction ( FEV, /VC ) in asthmatic subjects, and minimal restrictive disease (VC) in the pneumonia patients.
